P

Inventor

EDWARDS III CARL K

US23 patents
⚠️ This page may combine multiple inventors who share the name “EDWARDS III CARL K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOECHST MARION ROUSSEL INC

9 patents
US5905085AMay 18, 1999

Trans cyclopentanyl deazaadenyl analogs useful as immunosuppressants

HOECHST MARION ROUSSEL INC18 citations92
US5817660AOct 6, 1998

Trans cyclopentanyl purine analogs useful as immunosuppressants

HOECHST MARION ROUSSEL INC8 citations73
US5817661AOct 6, 1998

Trans cyclopentanyl purine analogs useful as immunosuppressants

HOECHST MARION ROUSSEL INC7 citations73
US5817672AOct 6, 1998

Trans cyclopentanyl purine analogs useful as immunosuppressants

HOECHST MARION ROUSSEL INC9 citations73
US5723466AMar 3, 1998

Trans cyclopentanyl purine analogs useful as immunosuppressants

HOECHST MARION ROUSSEL INC8 citations73
US5624930AApr 29, 1997

Carbocyclic nucleoside analogs useful as immunosuppressants

HOECHST MARION ROUSSEL INC7 citations73
US5605903AFeb 25, 1997

Carbocyclic nucleoside analogs useful as immunosuppressants

HOECHST MARION ROUSSEL INC8 citations73
US5929079AJul 27, 1999

Trans cyclopentanyl azaadenyl analogs useful as immunosuppressants

HOECHST MARION ROUSSEL INC2 citations62
US5916892AJun 29, 1999

Trans cyclopentanyl deazaadenyl analogs useful as immunosuppressants

HOECHST MARION ROUSSEL INC0 citations52

MARION MERRELL DOW INC

2 patents
US5244896ASep 14, 1993

Carbocyclic adenosine analogs useful as immunosuppressants

MARION MERRELL DOW INC42 citations92
US5470857ANov 28, 1995

Carbocyclic nucleoside analogs useful as immunosuppressants

MARION MERRELL DOW INC16 citations82

AMGEN INC

2 patents
US6306820B1Oct 23, 2001

Combination therapy using a TNF binding protein for treating TNF-mediated diseases

AMGEN INC64 citations90
US6989147B2Jan 24, 2006

Truncated soluble tumor necrosis factor type-I and type-II receptors

AMGEN INC19 citations87

(unassigned)

2 patents
US6541482B2Apr 1, 2003

Carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines

13 citations84
US6419919B2Jul 16, 2002

Method for the augmentation of gene expression

5 citations61

MERRELL PHARMA INC

2 patents
US5631258AMay 20, 1997

Method of effecting immunosuppression by administering carbocyclic adenosine analogs

MERRELL PHARMA INC6 citations73
US6420373B1Jul 16, 2002

9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines

MERRELL PHARMA INC6 citations57

INT MINERALS & CHEM CORP

2 patents
US4842862AJun 27, 1989

Immunostimulating agents

INT MINERALS & CHEM CORP14 citations71
US4778821AOct 18, 1988

Method for controlling helmintic parasites

INT MINERALS & CHEM CORP6 citations69

PITMAN MOORE INC

2 patents
US5028591AJul 2, 1991

Method for stimulating the immune system

PITMAN MOORE INC8 citations69
US4837202AJun 6, 1989

Method for stimulating the immune system

PITMAN MOORE INC16 citations69

MERRELL DOW PHARMA

1 patent
US5514688AMay 7, 1996

Carbocyclic adenosine analogs useful as immunosuppressants

MERRELL DOW PHARMA14 citations73

AVENTIS PHARMA INC

1 patent
US6436947B1Aug 20, 2002

Trans cyclopentanyl purine analogs useful as immunosuppressants

AVENTIS PHARMA INC2 citations62